Home › Major Depressive Disorder › New York › New York City
Pag-aaral pangklinika para sa Major Depressive Disorder sa New York City, NY
36 pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng New York City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Nagre-recruitPhase 3
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Nagre-recruitPhase 3
- Adams Clinical Harlem, New York
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Nagre-recruitPhase 3
- Fieve Clinical Research Inc, New York
- Adams Clinical Harlem, New York
- Manhattan Behavioral Medicine, New York
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Nagre-recruitPhase 3
- Manhattan Behavioral Medicine, New York
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Nagre-recruitPhase 3
- Fieve Clinical Research Inc, New York
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 2
- Ima Clinical Research - Nyc Midtown, New York
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Nagre-recruitPhase 3
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
DBS for TRD With the Medtronic Percept PC
Nagre-recruit
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Pattern Separation in Major Depressive Disorder
Nagre-recruitPhase 1
- New York State Psychiatric Institute (NYSPI), New York
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Nagre-recruitPhase 2
- Seaport Investigator Site, New York
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Nagre-recruitPhase 3
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Nagre-recruitPhase 2
- Draig Clinical Site, New York
- Draig Clinical Site, New York
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Nagre-recruit
- Mount Sinai Hospital, New York
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Nagre-recruitPhase 2
- Draig Clinical Site, New York
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, New York
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, New York
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Nagre-recruitPhase 2
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Nagre-recruitPhase 3
- Clinical Research Site, New York
- Clinical Research Site, New York
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
Nagre-recruit
- NYU Langone Health, New York
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Nagre-recruitPhase 2
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
tDCS: Sleep to Mood in Depression (S2M-D)
Nagre-recruit
- NYU Langone Health, New York
Triage Survey for Psychiatry Research Eligibility
Nagre-recruitObservasyonal na pag-aaral
- Adams Clinical, Harlem, New York
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Nagre-recruitPhase 2
- The Medical Research Network, LLC, New York
Aβ Dynamics in LLMD
Nagre-recruitPhase 4
- NYU Langone Health, New York
Maintenance rTMS for Depression (Maitr-De)
Nagre-recruit
- Weill Cornell Medicine, New York
Neutralizing Interleukin (IL)-6
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- Icahn School of Medicine at Mount Sinai, New York
Mindfulness-Based fMRI Neurofeedback for Depression
Nagre-recruit
- Columbia University Irving Medical Center, New York
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
Nagre-recruit
- Weill Cornell Medicine, New York
Biomarker-guided rTMS for Treatment Resistant Depression
Nagre-recruitPhase 3
- Weill Cornell Medicine, New York
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
Nagre-recruit
- NYU Langone Health, New York
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
Nagre-recruit
- Icahn School of Medicine at Mount Sinai, New York
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Nagre-recruitPhase 2
- Icahn School of Medicine at Mount Sinai, New York
Neural Circuit Effects of Ketamine in Depression
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
- Icahn School of Medicine at Mount Sinai, New York
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Nagre-recruitPhase 2
- Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Nagre-recruitPhase 4
- Clinical Research Site, New York
Pag-aaral para sa Major Depressive Disorder sa ibang lungsod
- Boston, MA31 pag-aaral
- Atlanta, GA25 pag-aaral
- Philadelphia, PA23 pag-aaral
- Orlando, FL19 pag-aaral
- Miami, FL18 pag-aaral
- Chicago, IL17 pag-aaral
- Tampa, FL17 pag-aaral
- San Diego, CA16 pag-aaral
- Houston, TX16 pag-aaral
- Little Rock, AR14 pag-aaral
- Austin, TX13 pag-aaral
- Las Vegas, NV13 pag-aaral
Iba pang pag-aaral sa New York City
- Kanser sa Suso136 pag-aaral
- Non-Small Cell Lung Cancer121 pag-aaral
- Kanser (lahat ng uri)109 pag-aaral
- Kanser sa Prostate103 pag-aaral
- Metastatic Cancer93 pag-aaral
- Colorectal Cancer78 pag-aaral
- Kanser sa Ovary69 pag-aaral
- Kanser sa Baga60 pag-aaral
- Multiple Myeloma60 pag-aaral
- Kanser sa Pancreas60 pag-aaral
- Kanser ng Endometrium52 pag-aaral
- Acute Myeloid Leukemia51 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.